Featured Research

from universities, journals, and other organizations

McMaster University Researchers Race To SARS Vaccine Development

Date:
October 2, 2003
Source:
McMaster University
Summary:
Researchers at McMaster University have turned a corner in the race to develop a vaccine for severe acute respiratory syndrome (SARS). A breakthrough has come with the work by professor Jim Mahony who cloned the gene that marks an important nuclear protein of the SARS virus.

Hamilton, ON (October 1, 2003) -- Researchers at McMaster University have turned a corner in the race to develop a vaccine for severe acute respiratory syndrome (SARS).

A breakthrough has come with the work by professor Jim Mahony who cloned the gene that marks an important nuclear protein of the SARS virus. A research team at McMaster then inserted the nuclear protein gene into an engineered common cold virus, or adenovirus vector, and will shortly test this in animals for the protective effects.

The team, headed by Jack Gauldie, chair of the department of pathology and molecular medicine and director of the Centre for Gene Therapeutics, includes professors Frank Graham, Mary Hitt and Mahony of the department of pathology and molecular medicine, along with professor Ludvik Prevec and technologist Uma Sankar of the department of biology.

Mahony's discovery was made using DNA sequence data from the SARS Vaccine Initiative (SAVI) of the British Columbia Centre for Disease Control, one of several laboratories the McMaster team is working with to develop a SARS vaccine based on the adenovirus vector that would act as a carrier within the body.

The McMaster group is also working with the SARS Initiative of the Canadian Institutes for Health Research (CIHR) and the National Centres of Excellence in Vaccine and Immunotherapy (CANVAC).

"This is an important step that will allow us to immediately determine whether we can provide protection against this virus with proper immunization," said Gauldie.

Dr. Mark Loeb, director of the Canadian SARS Research Network, says the discovery is an excellent next step in the development of a SARS vaccine.

"SARS is a deadly disease, particularly dangerous to those with compromised health," said Loeb, who is also an infectious disease specialist at McMaster University. "The development of a vaccine is important in ensuring Canadians are better protected against a reoccurrence of the syndrome."

Through the SAVI collaboration, the McMaster team obtained genes that encode important markers of the SARS virus. As a vaccine these genes are inserted into the backbone of the adenovirus that could then be administered directly to humans to produce a protective immune response.

Since SARS is a respiratory virus, the response must protect the lung surface from infection. Adenovirus vaccines are excellent candidates for this mucosal vaccine approach. In addition to generating strong antibody responses, the modified virus vaccine can also add lymphocyte-mediated protection, an important component of the body's defence system that seeks and destroys viral-infected cells.

The McMaster team is well connected to carry out this cutting edge research. Recently supported by the Ontario Research and Development Challenge Fund initiative to provide new vectors for gene therapy, the team is known around the world for their expertise in immunology and vaccine development.

With SAVI, the McMaster team has also produced a second SARS vaccine candidate. Depending on the outcome of the animal studies, both potential vaccines could be ready to test in human trials within the year.


Story Source:

The above story is based on materials provided by McMaster University. Note: Materials may be edited for content and length.


Cite This Page:

McMaster University. "McMaster University Researchers Race To SARS Vaccine Development." ScienceDaily. ScienceDaily, 2 October 2003. <www.sciencedaily.com/releases/2003/10/031002054648.htm>.
McMaster University. (2003, October 2). McMaster University Researchers Race To SARS Vaccine Development. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2003/10/031002054648.htm
McMaster University. "McMaster University Researchers Race To SARS Vaccine Development." ScienceDaily. www.sciencedaily.com/releases/2003/10/031002054648.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins